Company Profile
Genenta Science Stock Price, News & Catalysts
- Ticker:
- GNTA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Italy and listed in the U
Stock performance
1.30 USD (0.00%)
Close
Last updated: August 12, 2026
51.9M USD
Market cap
Why the stock is moving
As of Aug 12, 2026, GNTA was little changed and closed at $1.30. No new same-company headline was identified in the current news window.
Company overview
Business overview
Genenta Science is a cell-therapy company focused on engineered myeloid cells and cancer immunotherapy. Its platform aims to create a new class of cellular medicine for oncology.
Geographic Base and Sector Classification
Headquartered in Italy and listed in the U.S. as an ADR, Genenta has a global cell-therapy profile.
Business Model Characteristics
The company depends on platform validation, clinical data, and the ability to turn engineered-cell science into oncology value.
Position Within the Biotechnology Landscape
Genenta is a high-catalyst cell-therapy name whose stock reacts to translational and clinical milestones.
Future catalysts
- Genenta’s catalysts are its onco-immunology platform and any data that show the hematology / solid-tumor approach can still advance. The company remains early and data-dependent.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Genenta Science (GNTA)?
Genenta Science (GNTA) most recently closed at 1.30 USD, a 0.00% move versus the previous session.
What is the market cap of Genenta Science (GNTA)?
Genenta Science currently has a market capitalization of 51.9M USD on BioPharmSignal.
What does Genenta Science do?
Genenta Science is a cell-therapy company focused on engineered myeloid cells and cancer immunotherapy. Its platform aims to create a new class of cellular medicine for oncology.
On which exchange is GNTA stock listed?
Genenta Science (GNTA) is associated with NASDAQ, Italy and listed in the U, Biopharma.
What is Genenta?
Genenta’s catalysts are its onco-immunology platform and any data that show the hematology / solid-tumor approach can still advance.
Which conditions is Genenta Science targeting with Genenta?
Genenta Science is associated with oncology, cancer therapeutics, immunology based on its company overview and current catalyst commentary.
How does Genenta Science describe recent progress with Genenta?
Genenta’s catalysts are its onco-immunology platform and any data that show the hematology / solid-tumor approach can still advance.
What is Science?
Genenta Science is a cell-therapy company focused on engineered myeloid cells and cancer immunotherapy.